Browse: Companies | People | Financial Organizations
Home > Companies > Enobia Pharma

General Information
edit

Websiteenobia.com
CategoryBioTech
Employees
DescriptionGenetic bone disorder treatment

Offices
edit

Canada
CAN

Funding
edit

Total$90.1M
Series B, 8/07
OrbiMed Advisors
CTI Life Sciences Fund
Desjardins Venture Capital
Lothian Partners
C$40.1M
Series C, 8/09
OrbiMed Advisors
CTI Life Sciences Fund
Desjardins Venture Capital
Lothian Partners
$50M

Tags
edit

Enobia Pharma
edit

Enobia develops therapies to treat serious genetic bone disorders for which there are no approved treatments.

Milestones
edit

  • Dollar
    Enobia Pharma received $50M in Series C funding. (8/10/09)
    Posted 9/24/09 at 2:33pm
  • Dollar
    Enobia Pharma received C$40.1M in Series B funding. (8/07)
    Posted 9/24/09 at 2:33pm

Videos

Screenshots
edit

Sources

  1. enobia.com [edit]
  2. Enobia Raises US$50M from Current Investors in Series C Financing (enobia.com) [edit]
Edit This Page
Last Edited 9/24/09

Revision History RSS Picture

External Links
edit

Embed Widget

More

CrunchBase API

JSON Representation of this page.
More API docs »

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy